sitagliptin-phosphate and Pancreatic-Diseases

sitagliptin-phosphate has been researched along with Pancreatic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for sitagliptin-phosphate and Pancreatic-Diseases

Article	Year
Sitagliptin treatment increases GLP-1 without improving diabetes outcomes after total pancreatectomy with islet autotransplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:3 Topics: Case-Control Studies; Diabetes Mellitus; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Islets of Langerhans Transplantation; Pancreatectomy; Pancreatic Diseases; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Transplantation, Autologous; Treatment Outcome	2019

Article

Year

Sitagliptin treatment increases GLP-1 without improving diabetes outcomes after total pancreatectomy with islet autotransplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:3

Topics: Case-Control Studies; Diabetes Mellitus; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Islets of Langerhans Transplantation; Pancreatectomy; Pancreatic Diseases; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Transplantation, Autologous; Treatment Outcome

2019